Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Let's Invest: Are you prepared for do-it-yourself investing?

In our fourth segment of our “Let’s Invest” series’ with Jean-Paul Bureaud, executive director of FAIR Canada , we stay on the self-investing side with DIY – do-it-yourself investing. Bureaud goes over the pros and co...
Coreena Robertson | June 11, 2024 |

How to Buy Penny Stocks

A "penny stock" (also known as a micro-cap stock) is a publicly-traded stock with an extremely low price per share – usually under five dollars and often less than a dollar (hence the name "penny" stock). They are typically issued by small, less-established companies. Be ...
Stockhouse Editorial | July 24, 2019 |

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease

The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. In a Feb. 19 research note, analyst Yasmeen Rahimi reported that CymaBay Therapeutics Inc. (CBAY:NASDAQ) is having a strong Q1/19 with respect to cont...
Streetwise Reports | February 26, 2019 |

Ohio Industrial Packaging Maker Greif Records 24% Growth in Q3 Revenue; Shares Trading 14% Higher

Shares of global industrial packaging manufacturer Greif Inc. are trading 14% higher today after the company announced Q3/19 earnings. Industrial packaging products manufacturer and services provider Greif Inc. (GEF:NYSE) yesterday announced third quarter 2019 ear...
Streetwise Reports | August 30, 2019 |

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. This...
Streetwise Reports | January 9, 2020 |

Will the Fed Trigger Inflation This Time, Boosting Gold?

During Great Recession , many people feared that the Fed's quantitative easing would trigger high inflation , or even hyperinflation . As we know, it didn't happen. Why? Well, the main reason is that the Fed created money – that's true – but in the form of bank reserves. ...
Arkadiusz Sieron | May 29, 2020 |

Translate Bio and Sanofi Expand Partnership to Develop mRNA Vaccines

Translate Bio shares traded 45% higher reaching a new 52-week high after the company reported that it is expanding its collaboration with Sanofi Pasteur to develop mRNA vaccines across all infectious disease areas. Clinical-stage messenger RNA (mRNA) therapeutics c...
Streetwise Reports | June 24, 2020 |

The Game-changing FinTech Company You Need to Know About

Back in June , we introduced our Stockhouse investor audience to an emerging FinTech giant and took a deep dive into how this Canadian company is on the forefront of developing artificial intelligence (AI) that transforms data into knowledge. Toronto ON-based Analyti...
Dave Jackson | November 5, 2020 |

A New Age for Palladium and Lithium

(Robson Square, Vancouver | Image via New Age Metals) Two months ago, investors were dubbing palladium the hottest precious metal as prices reached US $1,600/oz. Today, they’re above US $1,800/oz. The continued upwards momentum for the metal is ...
Omri Wallach | December 2, 2019 |

Standard Lithium Demo Plant Operating Soon, First Production in 2022

This month, Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX) is targeted to switch on a relatively large-scale, proof-of-concept lithium extraction Demonstration Plant in southern Arkansas. If all goes reasonably as planned, it should take just a few months to prove the...
Streetwise Reports | January 24, 2020 |
1 2 3